US industry hopes for profile boost from ex-FDA appointee
This article was originally published in Clinica
Women have completed a clean sweep of power in the policy issue areas at US trade association AdvaMed, following the appointment of veteran FDA official, Elizabeth Jacobson, to head the Washington group's scientific, technical, regulatory and environmental activities. All three of the organisation's major policy divisions are now headed by women, with Carol Kelly in charge of reimbursement, and Marge Searing, heading the organisation's international office.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.